Leveragen Inc.
Leveragen, Inc.
- UEI
- MBHPE8GND6R6
- CAGE
- 85G53
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- leveragen.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Generation of two (2) lines of mice in which the ctcf gene is modified by crispr gene editing to contain either (1) an… | National Institute of Allergy and Infectious Diseases | $60,000 | |
| At least two N1 mutants, two male homozygous, and two female homozygous mice with sequence-validated genotypes, with a… | National Institute of Allergy and Infectious Diseases | $57,919 |
Quick answers
What is Leveragen Inc.'s UEI?
Leveragen Inc.'s Unique Entity ID (UEI) in SAM.gov is MBHPE8GND6R6.
What is Leveragen Inc.'s CAGE code?
Leveragen Inc.'s CAGE code is 85G53.
What is Leveragen Inc.'s primary NAICS code?
Leveragen Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Leveragen Inc. registered in SAM.gov?
Leveragen Inc.'s SAM.gov registration expired on July 31, 2025.
What is Leveragen Inc.'s most recent federal award?
Leveragen Inc.'s most recent federal contract award is Generation of two (2) lines of mice in which the ctcf gene is modified by crispr gene editing to contain either (1) an… (75N93023P01167), from National Institute of Allergy and Infectious Diseases, on August 30, 2023.
On GovTribe
See Leveragen Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors